ENTITY
Ocumension Therapeutics

Ocumension Therapeutics (1477 HK)

50
Analysis
Health Care • China
Ocumension Therapeutics operates as a pharmaceutical company. The Company focuses on identifying, developing, and commercializing ophthalmic therapies. Ocumension Therapeutics serves customers in the United States and China.
more
•12 Jul 2020 15:57

ECM Weekly (12 July 2020) - Ocumension and Smoore, Simcere, Blue Moon, Weihai City Bank, Radiance

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Hong...

Share
•09 Jul 2020 13:29

Ocumension Therapeutics IPO: Trading Debut

Ocumension Therapeutics (1477 HK) is a China-based ophthalmic pharmaceutical company dedicated to identifying, developing and commercializing...

Logo
499 Views
Share
•09 Jul 2020 11:07

Ocumension (欧康结视) IPO Trading: Share Could Double Thanks to Record Demand

Ocumension raised HKD 1,424 million (USD 183 m) from its global offering and will list on the Hong Kong Stock Exchange tomorrow. In our previous...

Logo
529 Views
Share
•05 Jul 2020 09:36

ECM Weekly (4 July 2020) - Smoore, Ocumension, Zhenro Services, Archosaur Games

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. It...

Share
•30 Jun 2020 20:49

Ocumension Therapeutics IPO: Valuation Insights

Ocumension Therapeutics (1477 HK) is a China-based ophthalmic pharmaceutical company dedicated to identifying, developing and commercializing...

Logo
690 Views
Share
x